PORT WASHINGTON, N.Y., June 15, 2011 -
Pall Corporation (NYSE:PLL),
a global leader in filtration, separation and purification, introduces
Allegro™ 200L Single-Use Mixer for high-performance mixing in
biopharmaceutical applications from pilot scale to full production. This
latest addition to the extensive portfolio of Pall
Allegro single-use solutions and services substantially improves the
efficiency of critical mixing processes throughout the drug production
Allegro(TM) 200L single-use high performance mixer for multiple applications (Photo: Business Wire)
The Allegro 200L mixer is designed to provide exceptional mixing
performance for a wide range of liquid-liquid and solid-liquid mixing
applications, including compounding, formulation, buffer and media
preparation, and pH/conductivity adjustment. It is especially engineered
for difficult mixing applications, including processes utilizing dense
powders or high viscosities, or applications requiring repeatable,
Product features include:
Impeller designed for low-shear, general purpose mixing.
Clockwise or counter-clockwise rotation for complete flexibility in
up-flow and down-flow mixing depending on process requirements.
Very easy installation and removal.
Consistent mixing performance in volumes from 50-200 liters.
Flush drain valve to prevent entrapment of high density solids during
Same high quality film as in Pall’s Allegro biocontainer product range
in order to reduce validation requirements
Good Engineering Practice (GEP)-compliant design for efficient mixing
“Reduced drug development timelines, smaller batch sizes, increased
safety requirements and more stringent validation guidelines are all
driving the demand for single-use solutions in drug production. Adding a
high-performance, single-use mixing solution to Pall’s Allegro
single-use platform that is particularly well suited for critical
applications gives biopharmaceutical manufacturers an important new tool
to improve process efficiencies and help speed product to market,” said
Ken Frank, senior vice president of Pall Corporation and president of
Pall’s Biopharmaceutical Division.
Pall Allegro™ platform provides a complete range of single-use
processing solutions, technical support, and validation services to
support all biopharmaceutical development applications from upstream
through downstream as well as formulation and filling. The
high-performance Allegro 200L Single-Use Mixer further strengthens
Pall’s growing portfolio of single-use total fluid management solutions
by simplifying qualification and validation requirements, and
Life Sciences provides cutting-edge products and services to meet
the demanding needs of customers discovering, developing and producing
biotech drugs, vaccines and classic pharmaceuticals. Pall technologies
are also used to collect and process blood components and help protect
patients from hospital-acquired infections. The company’s membranes and
membrane devices optimize detection and sample preparation in the drug
research, clinical diagnostics, genomics, and proteomics markets. Pall
is a leading provider of separation systems and single-use filtration
and purification technologies to pharmaceutical and biotechnology
companies to support faster development of new drugs and vaccines that
are safer and require less energy and water to produce.
About Pall Corporation
Pall Corporation (NYSE:PLL)
is a filtration, separation and purification leader providing solutions
to meet the critical fluid management needs of customers across the
broad spectrum of life sciences and industry. Pall works with customers
to advance health, safety and environmentally responsible technologies.
The Company’s engineered products enable process and product innovation
and minimize emissions and waste. Pall Corporation, with total revenues
of $2.4 billion for fiscal 2010, is an S&P 500 company with more than
10,000 employees serving customers worldwide. To see how Pall is helping
enable a greener, safer, more sustainable future, follow us on Twitter @PallCorporation
or visit www.pall.com/green.